The 20th edition of BioAsia – The Marquee Healthcare and Life Sciences event, organized by the Government of Telangana, has announced that the coveted Genome Valley Excellence Award for the year 2023 will be conferred upon Prof. Robert S. Langer, in light of his pioneering research that has led to the development of the first commercial mRNA vaccines used for a variety of infectious diseases. Langer is currently the David H. Koch Institute Professor at Massachusetts Institute of Technology (MIT), USA. He is also being acknowledged for his exemplary research in human health, including the detection, monitoring, and treatment of cancer. A veteran in his field, his remarkable contributions to biomedical and therapeutic research include developing long-term and controlled-release drug delivery systems used for a variety of applications including cancer therapy, insulin, and vaccines.
Related Posts
Study reveals family offices need to strengthen cyber risk defence
June 03: New global research from Ocorian, the specialist global provider of services for asset managers and owners, including private…
BLS International reports highest ever quarterly performance
New Delhi, 12th November 2025: BLS International Services Limited, a trusted global tech-enabled services partner for governments and citizens, announced…
India Jewellery Park Mumbai Construction Gets Underway This Month: GJEPC
6th January 2025: The first-of-its-kind India Jewellery Park Mumbai’s construction will commence this month, announced Mr. Vipul Shah, Chairman, Gem…